Cerebral Palsy in Extremely Preterm Infants

Maria Hafström1,2,3, Karin Källén4, Fredrik Serenius5,6

  • 1Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden; maria.hafstrom@ntnu.no.

Pediatrics
|December 10, 2017
PubMed

Insights

Cerebral palsy (CP) affects over 10% of extremely preterm infants, often with severe disabilities and comorbidities. Comprehensive, long-term follow-up is crucial for accurate outcome assessment in these children.

Area of Science:

  • Pediatrics
  • Neurology
  • Developmental Pediatrics

Background:

  • Extremely preterm infants face a high risk of cerebral palsy (CP).
  • CP in this population is frequently associated with neurodevelopmental comorbidities.
  • Understanding the lifetime prevalence and spectrum of CP and its associated conditions is critical.

Purpose of the Study:

  • To determine the lifetime prevalence of CP in extremely preterm infants.
  • To characterize the type, severity, and comorbidities associated with CP.
  • To evaluate factors influencing outcome assessment, including age and data sources.

Main Methods:

  • Prospective, population-based cohort study of Swedish children born before 27 weeks' gestation (2004-2007).
  • Data collection included neonatal records, clinical/neuropsychological assessments at 2.5 and 6.5 years, and medical chart reviews.
  • Outcome data was obtained for 94.5% of eligible children alive at 1 year.

Main Results:

  • 10.5% of eligible children received a lifetime CP diagnosis.
  • Of those with CP, 76% were ambulatory, 29% were diagnosed after 2.5 years, and 55% had severe disability.
  • Children with CP had a higher probability of incomplete evaluation compared to those without CP.

Conclusions:

  • Extremely preterm infants with CP frequently present with diverse comorbidities and severe disability.
  • Emphasizes the necessity of long-term, comprehensive follow-up using multiple information sources for accurate disability assessment.
  • Highlights the challenges in outcome evaluation for this vulnerable population.
Abstract